---
figid: PMC8327170__fphar-12-699629-g003
figtitle: 'Mcl-1 Inhibition: Managing Malignancy in Multiple Myeloma'
organisms:
- Mus musculus
- Rattus norvegicus
- Homo sapiens
- Equus asinus x Equus caballus
- Sorbus aucuparia
organisms_ner:
- Rattus norvegicus
- Mus musculus
- Homo sapiens
- Danio rerio
pmcid: PMC8327170
filename: fphar-12-699629-g003.jpg
figlink: /pmc/articles/PMC8327170/figure/F3/
number: F3
caption: Bone marrow microenvironment (BMM) in MM. BMM facilitates the long term survival
  of MM. Stromal cells in BM regulate anti-apoptotic proteins by secreting a variety
  of signaling molecules including IL-6 and IFN-α that trigger JAK/STAT pathway, leading
  to the upregulation of Mcl-1, Bcl-xL, and VEGF. VEGF promotes IL-6 induction in
  neighboring BMCs. Furthermore, IL-6 induces survival of MM cells via Ras/MAPK pathway,
  which modulates the expression of Mcl-1 The tumor necrosis factor (TNF) family including
  BAFF and APRIL are other stimuli from the BMM that induce expression of both Mcl-1
  and Bcl-2 via tumor necrosis factor receptor-associated factors (TRAFs) including
  BAFF-R, BCMA, and TACI. IGF-1 is another stimulus that acts by downregulating Bim,
  leading to release Mcl-1. MM cases have shown chromosomal amplification of 1q21
  region, where the gene coding for Mcl-1 and IL-6R are located.
papertitle: 'Mcl-1 Inhibition: Managing Malignancy in Multiple Myeloma.'
reftext: Omar S. Al-Odat, et al. Front Pharmacol. 2021;12:699629.
year: '2021'
doi: 10.3389/fphar.2021.699629
journal_title: Frontiers in Pharmacology
journal_nlm_ta: Front Pharmacol
publisher_name: Frontiers Media S.A.
keywords: multiple myeloma | drug resistant | Mcl-1 | Bcl-2 homology 3 mimetics |
  apoptosis
automl_pathway: 0.9318305
figid_alias: PMC8327170__F3
figtype: Figure
redirect_from: /figures/PMC8327170__F3
ndex: ''
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC8327170__fphar-12-699629-g003.html
  '@type': Dataset
  description: Bone marrow microenvironment (BMM) in MM. BMM facilitates the long
    term survival of MM. Stromal cells in BM regulate anti-apoptotic proteins by secreting
    a variety of signaling molecules including IL-6 and IFN-α that trigger JAK/STAT
    pathway, leading to the upregulation of Mcl-1, Bcl-xL, and VEGF. VEGF promotes
    IL-6 induction in neighboring BMCs. Furthermore, IL-6 induces survival of MM cells
    via Ras/MAPK pathway, which modulates the expression of Mcl-1 The tumor necrosis
    factor (TNF) family including BAFF and APRIL are other stimuli from the BMM that
    induce expression of both Mcl-1 and Bcl-2 via tumor necrosis factor receptor-associated
    factors (TRAFs) including BAFF-R, BCMA, and TACI. IGF-1 is another stimulus that
    acts by downregulating Bim, leading to release Mcl-1. MM cases have shown chromosomal
    amplification of 1q21 region, where the gene coding for Mcl-1 and IL-6R are located.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - Vegfa
  - Il6r
  - Mcl1
  - Tmprss5
  - Stat3
  - Ifngr1
  - Bcl2l1
  - Il6
  - Ephb1
  - Traf3
  - Bcl2
  - Tnfsf13
  - Tnfsf13b
  - Igf1
  - Bcl2l11
  - Igf1r
  - Ifna
  - Il6ra
  - ras
  - Hras
  - Kras
  - Rem1
  - Zhx2
  - Mdk
  - Ephb2
  - Mapk1
  - Tnfrsf13c
  - Tnfrsf13b
  - Tnfrsf17
  - VEGFA
  - VEGFB
  - VEGFC
  - VEGFD
  - PGF
  - IFNA1
  - IL6R
  - MCL1
  - APRT
  - MFAP1
  - JAK1
  - JAK2
  - JAK3
  - TYK2
  - SOAT1
  - STAT1
  - STAT2
  - STAT3
  - STAT4
  - STAT6
  - STAT5A
  - STAT5B
  - IFNGR1
  - KRAS
  - HRAS
  - NRAS
  - IL6
  - ZHX2
  - ARAF
  - BRAF
  - RAF1
  - MAP2K7
  - MAP2K1
  - MAP2K2
  - EPHB2
  - MAPK1
  - MAPK3
  - TNFRSF13C
  - TRAF3
  - BCL2
  - TRAF1
  - TRAF2
  - TRAF4
  - TRAF5
  - TRAF6
  - TRAF7
  - TNFSF13
  - ANP32B
  - TNFSF13B
  - TNFRSF13B
  - TNFRSF17
  - IGF1
  - BCL2L11
  - IGF1R
  - vegfaa
  - il6r
  - stat1b
  - stat4
  - stat3
  - rab1ab
  - il6
  - traf3
  - chmp2a
  - tnfsf13
  - igf1
  - bcl2l11
---
